Maria Albanese - Concepedia

Author

Maria Albanese

Also Known As

Adriana Fallacara, Albanese, Maria, Angelo Ranieri, Bruno Colombo, Cristina Tassorelli, M A Albanese, M ALBANESE, M Albanese, M. A. Albanese, M. Albanese

184

Publications

6.1K

Citations

H-Index

176

Concepts

All Affiliations

University of Rome Tor Vergata Istituti di Ricovero e Cura a Carattere Scientifico Fondazione Santa Lucia Istituto Neurologico Mediterraneo University of Wisconsin–Madison

About

Maria Albanese is an author at University of Rome Tor Vergata specializing in medicine, neurology, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Education	9	9	253
2	Arts	3	3	58
3	Engineering	2	2	65
4	Health Sciences	2	2	69
5	Management	1	1	19

Maria Albanese

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Orexinergic System Dysregulation, Sleep Impairment, and Cognitive Decline in Alzheimer Disease Claudio Liguori, Andrea Romigi, Marzia Nuccetelli, JAMA Neurology	2014	328
Ensuring reliability of outcome measures in multicenter clinical trials of treatments for acute ischemic stroke. The program developed for the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Maria Albanese, William R. Clarke, Harold P. Adams, Stroke	1994	137
Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction Gijs Kooij, Claudio Derada Troletti, Alessandro Leuti, Haematologica	2019	113
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, The Journal of Headache and Pain	2022	112
Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, The Journal of Headache and Pain	2022	101
Long‐term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high‐frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study Piero Barbanti, Cinzia Aurilia, Sabina Cevoli, Headache The Journal of Head and Face Pain	2021	91
Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression Maria Albanese, Sara Zagaglia, Doriana Landi, Journal of Neuroinflammation	2016	82
Sleep disorders in adult-onset myotonic dystrophy type 1: a controlled polysomnographic study Andrea Romigi, Francesca Izzi, Valerio Pisani, European Journal of Neurology	2011	81
Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study Mariangela Pierantozzi, Fabio Placidi, Claudio Liguori, Sleep Medicine SleepSleep DisorderParkinson DiseaseSleep ArchitectureNeurology	2016	77
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3‐month observational, longitudinal, cohort, multicenter, Italian real‐life study Fabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli, European Journal of Neurology	2021	75

Page 1